(Total Views: 374)
Posted On: 07/07/2020 8:27:02 PM
Post# of 11803
Re: mrmaskedman #10891
Mr. masked man,
I’d sure like to answer your questions as they are both good questions. But I have asked multiple stock experts on how we get back to Pinks and every single one said something different. Perhaps it’s better being traded on the grays anyways. Less stock manipulation occurs.
Testing: I have no idea other than what KB stated in his press releases. But he did post some test results a few weeks ago. However, I understand, now, the FDA recently changed the testing protocol specifically for antigen tests. So I think KB is sorting out these new guidelines as we speak.
What we need here are not my comments. We need some questions possibly answered by KB. Like:
1. Did the FDA change the testing protocol for our GenViro Test Kits?
2. When might the new testing for the FDA be completed?
3. Are you going to start selling kits overseas relatively soon......without waiting any longer for FDA Emergency authorizations? Is there a downside to doing this?
4. Do you have any comments on the SEC rebuttal document posted today?
I am sure all of these questions will be answered in the next PR. It is what we need.
I’d sure like to answer your questions as they are both good questions. But I have asked multiple stock experts on how we get back to Pinks and every single one said something different. Perhaps it’s better being traded on the grays anyways. Less stock manipulation occurs.
Testing: I have no idea other than what KB stated in his press releases. But he did post some test results a few weeks ago. However, I understand, now, the FDA recently changed the testing protocol specifically for antigen tests. So I think KB is sorting out these new guidelines as we speak.
What we need here are not my comments. We need some questions possibly answered by KB. Like:
1. Did the FDA change the testing protocol for our GenViro Test Kits?
2. When might the new testing for the FDA be completed?
3. Are you going to start selling kits overseas relatively soon......without waiting any longer for FDA Emergency authorizations? Is there a downside to doing this?
4. Do you have any comments on the SEC rebuttal document posted today?
I am sure all of these questions will be answered in the next PR. It is what we need.
(0)
(0)
